The Vanguard Group 13D and 13G filings for Elevation Oncology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-30 9:33 pm Sale | 2024-12-31 | 13G | Elevation Oncology, Inc. ELEV | The Vanguard Group | 2,610,045 4.410% | -461,535 (-15.03%) | Filing |
| 2024-11-12 2:22 pm Unchanged | 2024-09-30 | 13G | Elevation Oncology, Inc. ELEV | The Vanguard Group | 3,071,580 5.190% | 0 (Unchanged) | Filing |
| 2024-11-04 11:49 am Purchase | 2024-09-30 | 13G | Elevation Oncology, Inc. ELEV | The Vanguard Group | 3,071,580 5.190% | 3,071,580 (New Position) | Filing |